Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.

Alzheimers Dement (N Y) · 2017 · PMC5651373 · PMID 29067316

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, this did not reach statistical significance and was not supported by results in any of the other clinical scales or correlations to antibody titers.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.